Radiotherapy in early stage Hodgkin's lymphoma: The importance of volume and treatment position

Role of radiotherapy in Hodgkin lymphoma

Baues, Christian
Marnitz, Simone
Lukas, Peter
Herfarth, Klaus
Engenhart-Cabillic, Rita
Schmidberger, Heinz
Eich, Hans

January 2022

Background The role of radiotherapy (RT) in the treatment of Hodgkin lymphoma (HL) has changed consi...

Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma: when should they be considered and which questions remain open?

Lohr, Frank
Georg, Dietmar
Cozzi, Luca
Eich, Hans Theodor
Weber, Damien Charles
Koeck, Julia
Knäusl, Barbara
Dieckmann, Karin
Abo-Madyan, Yasser
Fiandra, Christian
Mueller, Rolf-Peter
Engert, Andreas
Ricardi, Umberto

October 2014

PURPOSE Hodgkin lymphoma (HL) is a highly curable disease. Reducing late complications and second...

Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin's lymphoma: dosimetric comparison and clinical considerations

Fiandra C
Filippi AR
Catuzzo P
Botticella A
Ciammella P
Franco P
Casanova Borca V
Ragona R
Tofani S
Ricardi U.

January 2012

BACKGROUND: Radiotherapy in Hodgkin's Lymphoma (HL) is currently evolving with new attempts to furth...

Radiotherapy in early stage Hodgkin's lymphoma: The importance of volume and treatment position

Reymen, Bart
Spiessens, Sylvie
Lievens, Yolande

May 2010

This planning study in Hodgkin's disease confirmed smaller irradiated volumes and subsequently lower...

Radiotherapy for Early Mediastinal Hodgkin Lymphoma According to the German Hodgkin Study Group (GHSG): The Roles of Intensity-Modulated Radiotherapy and Involved-Node Radiotherapy

Koeck J
Abo-Madyan Y
Lohr F
Stieler F
Kriz J
Mueller RP
Wenz F
Eich HT

January 2012

Purpose: Cure rates of early Hodgkin lymphoma (HL) are high, and avoidance of late complications and...

Involved-nodal radiation therapy leads to lower doses to critical organs-at-risk compared to involved-field radiation therapy

Mulvihill, David J.
McMichael, Kevin
Goyal, Sharad
Drachtman, Richard
Weiss, Aaron
Khan, Atif J.

January 2014

Radiation Therapy Planning for Early-Stage Hodgkin Lymphoma: Experience of the International Lymphoma Radiation Oncology Group

M. V. Maraldo
B. S. Dabaja
A. R. Filippi
T. Illidge
R. Tsang
U. Ricardi
P. M. Petersen
D. A. Schut
J. Garcia
J. Headley
A. Parent
B. Guibord
R. Ragona
L. Specht

January 2015

Early-stage Hodgkin lymphoma (HL) is a rare disease, and the location of lymphoma varies considerabl...

Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines.

Girinsky, T.
Maazen, R.W.M. van der
Specht, L.
Aleman, B.
Poortmans, P.M.P.
Lievens, Y.
Meijnders, P.
Ghalibafian, M.
Meerwaldt, J.H.
Noordijk, E.M.

January 2006

BACKGROUND AND PURPOSE: To describe new concepts for radiation fields in patients with early stage H...

Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma When should they be considered and which questions remain open?

Lohr F
Georg D
Cozzi L
Eich HT
Weber DC
Koeck J
Knausl B
Dieckmann K
Abo-Madyan Y
Fiandra C
Mueller RP
Engert A
Ricardi U

January 2014

Purpose. Hodgkin lymphoma (HL) is a highly curable disease. Reducing late complications and second m...

Comparison and Evaluation of Different Treatment Plans with IFRT Field and 6 and 18 MV Energies in Hodgkin’s Lymphoma Involvement Neck and Mediastinum

Tavakoli M. B.
Maleki M.
Akhavan A.
Hadisinia T.
Abedi I.
Amouheidari A.

March 2018

Background: Radiotherapy with large mantle field is an effective technique in increasing the risk of...

Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: a comparative planning study

Weber, Damien
Peguret, Nicolas
Dipasquale, Giovanna
Cozzi, Luca

January 2009

PURPOSE: A comparative treatment planning study was performed to compare volumetric-modulated arc (R...

Hodgkin's lymphoma emerging radiation treatment techniques: trade-offs between late radio-induced toxicities and secondary malignant neoplasms.

Laura Cella
Manuel Conson
Maria Cristina Pressello
Silvia Molinelli
Uwe Schneider
Vittorio Donato
Roberto Orecchia
Marco Salvatore
Roberto Pacelli

January 2013

Background: Purpose of this study is to explore the trade-offs between radio-induced toxicities and ...

A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk.

Koh, Eng-Siew
Tran, Tu Huan
Heydarian, Mostafa
Sachs, Rainer K
Tsang, Richard W
Brenner, David J
Pintilie, Melania
Xu, Tony
Chung, June
Paul, Narinder
Hodgson, David C

March 2007

BackgroundHodgkin's lymphoma (HL) survivors who undergo radiotherapy experience increased risks of s...

Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: is it better than three dimensional conformal radiotherapy?

Vitaliana De Sanctis
Chiara Bolzan2
Marco D’arienzo2
Stefano Bracci1§
Alessandro Fanelli1
Maria Christina Cox3
Maurizio Valeriani1
Mattia Falchetto Osti
Giuseppe Minniti1
Laura Chiacchiararelli2
Riccardo Maurizi Enrici

January 2012

Cure rate of early Hodgkin Lymphoma are high and avoidance of late toxicities is of paramount import...

Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: Is it better than three dimensional conformal radiotherapy?

De Sanctis V.
Bolzan C.
D'Arienzo M.
Bracci S.
Fanelli A.
Cox M. C.
Valeriani M.
Osti M. F.
Minniti G.
Chiacchiararelli L.
Enrici R. M.

January 2012

Background: Cure rate of early Hodgkin Lymphoma are high and avoidance of late toxicities is of para...

Role of radiotherapy in Hodgkin lymphoma

Baues, Christian
Marnitz, Simone
Lukas, Peter
Herfarth, Klaus
Engenhart-Cabillic, Rita
Schmidberger, Heinz
Eich, Hans

January 2022

Background The role of radiotherapy (RT) in the treatment of Hodgkin lymphoma (HL) has changed consi...

Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma: when should they be considered and which questions remain open?

Lohr, Frank
Georg, Dietmar
Cozzi, Luca
Eich, Hans Theodor
Weber, Damien Charles
Koeck, Julia
Knäusl, Barbara
Dieckmann, Karin
Abo-Madyan, Yasser
Fiandra, Christian
Mueller, Rolf-Peter
Engert, Andreas
Ricardi, Umberto

October 2014

PURPOSE Hodgkin lymphoma (HL) is a highly curable disease. Reducing late complications and second...

Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin's lymphoma: dosimetric comparison and clinical considerations

Fiandra C
Filippi AR
Catuzzo P
Botticella A
Ciammella P
Franco P
Casanova Borca V
Ragona R
Tofani S
Ricardi U.

January 2012

BACKGROUND: Radiotherapy in Hodgkin's Lymphoma (HL) is currently evolving with new attempts to furth...

Radiotherapy in early stage Hodgkin's lymphoma: The importance of volume and treatment position

Reymen, Bart
Spiessens, Sylvie
Lievens, Yolande

May 2010

This planning study in Hodgkin's disease confirmed smaller irradiated volumes and subsequently lower...

Radiotherapy for Early Mediastinal Hodgkin Lymphoma According to the German Hodgkin Study Group (GHSG): The Roles of Intensity-Modulated Radiotherapy and Involved-Node Radiotherapy

Koeck J
Abo-Madyan Y
Lohr F
Stieler F
Kriz J
Mueller RP
Wenz F
Eich HT

January 2012

Purpose: Cure rates of early Hodgkin lymphoma (HL) are high, and avoidance of late complications and...

Involved-nodal radiation therapy leads to lower doses to critical organs-at-risk compared to involved-field radiation therapy

Mulvihill, David J.
McMichael, Kevin
Goyal, Sharad
Drachtman, Richard
Weiss, Aaron
Khan, Atif J.

January 2014

Radiation Therapy Planning for Early-Stage Hodgkin Lymphoma: Experience of the International Lymphoma Radiation Oncology Group

M. V. Maraldo
B. S. Dabaja
A. R. Filippi
T. Illidge
R. Tsang
U. Ricardi
P. M. Petersen
D. A. Schut
J. Garcia
J. Headley
A. Parent
B. Guibord
R. Ragona
L. Specht

January 2015

Early-stage Hodgkin lymphoma (HL) is a rare disease, and the location of lymphoma varies considerabl...

Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines.

Girinsky, T.
Maazen, R.W.M. van der
Specht, L.
Aleman, B.
Poortmans, P.M.P.
Lievens, Y.
Meijnders, P.
Ghalibafian, M.
Meerwaldt, J.H.
Noordijk, E.M.

January 2006

BACKGROUND AND PURPOSE: To describe new concepts for radiation fields in patients with early stage H...

Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma When should they be considered and which questions remain open?

Lohr F
Georg D
Cozzi L
Eich HT
Weber DC
Koeck J
Knausl B
Dieckmann K
Abo-Madyan Y
Fiandra C
Mueller RP
Engert A
Ricardi U

January 2014

Purpose. Hodgkin lymphoma (HL) is a highly curable disease. Reducing late complications and second m...

Comparison and Evaluation of Different Treatment Plans with IFRT Field and 6 and 18 MV Energies in Hodgkin’s Lymphoma Involvement Neck and Mediastinum

Tavakoli M. B.
Maleki M.
Akhavan A.
Hadisinia T.
Abedi I.
Amouheidari A.

March 2018

Background: Radiotherapy with large mantle field is an effective technique in increasing the risk of...

Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: a comparative planning study

Weber, Damien
Peguret, Nicolas
Dipasquale, Giovanna
Cozzi, Luca

January 2009

PURPOSE: A comparative treatment planning study was performed to compare volumetric-modulated arc (R...

Hodgkin's lymphoma emerging radiation treatment techniques: trade-offs between late radio-induced toxicities and secondary malignant neoplasms.

Laura Cella
Manuel Conson
Maria Cristina Pressello
Silvia Molinelli
Uwe Schneider
Vittorio Donato
Roberto Orecchia
Marco Salvatore
Roberto Pacelli

January 2013

Background: Purpose of this study is to explore the trade-offs between radio-induced toxicities and ...

A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk.

Koh, Eng-Siew
Tran, Tu Huan
Heydarian, Mostafa
Sachs, Rainer K
Tsang, Richard W
Brenner, David J
Pintilie, Melania
Xu, Tony
Chung, June
Paul, Narinder
Hodgson, David C

March 2007

BackgroundHodgkin's lymphoma (HL) survivors who undergo radiotherapy experience increased risks of s...

Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: is it better than three dimensional conformal radiotherapy?

Vitaliana De Sanctis
Chiara Bolzan2
Marco D’arienzo2
Stefano Bracci1§
Alessandro Fanelli1
Maria Christina Cox3
Maurizio Valeriani1
Mattia Falchetto Osti
Giuseppe Minniti1
Laura Chiacchiararelli2
Riccardo Maurizi Enrici

January 2012

Cure rate of early Hodgkin Lymphoma are high and avoidance of late toxicities is of paramount import...

Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: Is it better than three dimensional conformal radiotherapy?

De Sanctis V.
Bolzan C.
D'Arienzo M.
Bracci S.
Fanelli A.
Cox M. C.
Valeriani M.
Osti M. F.
Minniti G.
Chiacchiararelli L.
Enrici R. M.

January 2012

Background: Cure rate of early Hodgkin Lymphoma are high and avoidance of late toxicities is of para...

Role of radiotherapy in Hodgkin lymphoma

Baues, Christian
Marnitz, Simone
Lukas, Peter
Herfarth, Klaus
Engenhart-Cabillic, Rita
Schmidberger, Heinz
Eich, Hans

January 2022

Background The role of radiotherapy (RT) in the treatment of Hodgkin lymphoma (HL) has changed consi...

Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma: when should they be considered and which questions remain open?

Lohr, Frank
Georg, Dietmar
Cozzi, Luca
Eich, Hans Theodor
Weber, Damien Charles
Koeck, Julia
Knäusl, Barbara
Dieckmann, Karin
Abo-Madyan, Yasser
Fiandra, Christian
Mueller, Rolf-Peter
Engert, Andreas
Ricardi, Umberto

October 2014

PURPOSE Hodgkin lymphoma (HL) is a highly curable disease. Reducing late complications and second...

Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin's lymphoma: dosimetric comparison and clinical considerations

Fiandra C
Filippi AR
Catuzzo P
Botticella A
Ciammella P
Franco P
Casanova Borca V
Ragona R
Tofani S
Ricardi U.

January 2012

BACKGROUND: Radiotherapy in Hodgkin's Lymphoma (HL) is currently evolving with new attempts to furth...

Radiotherapy in early stage Hodgkin's lymphoma: The importance of volume and treatment position

Abstract

Extracted data

Radiotherapy in early stage Hodgkin's lymphoma: The importance of volume and treatment position

Abstract

Extracted data

Topics

Related items

Topics

Related items